US 6,599,535 B2 · Pharmaceutical compositions

Abstract

A pharmaceutical composition in the form of a solid dispersion comprising a macrolide, e.g. a rapamycin or an ascomycin, and a carrier medium.

Claims8

Dependent claims

A pharmaceutical composition in the form of a solid dispersion comprising 33-epichloro-33-desoxy-ascomycin and a carrier medium, wherein the pharmaceutical composition does not contain a surfactant.

Dependencies are inferred from the claim text.

Facts

Application

10/194,826Filed 12 Jul 2002 · continuation

Priority

GB 951439714 Jul 1995

Published

US 2003/0008835 A19 Jan 2003

Granted

29 Jul 2003

Term ends

Not estimatedThe source records don’t support an estimate.

Classification32 codes

A61K 31/4745
Ortho- or peri-condensed with heterocyclic ring systems: condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
A61K 9/145
Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried,…: with…
A61K 9/146
Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried,…: with…
A61K 31/436
Ortho- or peri-condensed with heterocyclic ring systems: the heterocyclic ring system containing a six-membered ring having oxygen as a ring…

Family

PCT/EP96/03066Parent of this continuation · filed 12 Jul 1996

Application09/374,899Parent of this continuation · filed 13 Aug 1999

Application09/725,733Parent of this continuation · filed 29 Nov 2000

US 2003/0008835 A1Pre-grant publication · published 9 Jan 2003

US 6,197,781 B1Parent of this continuation

Application08/981,952Parent of this continuation

US 6,004,973 AParent of this continuation

US 6,599,535 B2This patent

From the US filing history. Foreign family members aren’t listed.

Abstract

A pharmaceutical composition in the form of a solid dispersion comprising a macrolide, e.g. a rapamycin or an ascomycin, and a carrier medium.

Facts

Application

10/194,826Filed 12 Jul 2002 · continuation

Priority

GB 951439714 Jul 1995

Published

US 2003/0008835 A19 Jan 2003

Granted

29 Jul 2003

Term ends

Not estimatedThe source records don’t support an estimate.

Classification32 codes

A61K 31/4745
Ortho- or peri-condensed with heterocyclic ring systems: condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
A61K 9/145
Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried,…: with…
A61K 9/146
Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried,…: with…
A61K 31/436
Ortho- or peri-condensed with heterocyclic ring systems: the heterocyclic ring system containing a six-membered ring having oxygen as a ring…

Family

PCT/EP96/03066Parent of this continuation · filed 12 Jul 1996

Application09/374,899Parent of this continuation · filed 13 Aug 1999

Application09/725,733Parent of this continuation · filed 29 Nov 2000

US 2003/0008835 A1Pre-grant publication · published 9 Jan 2003

US 6,197,781 B1Parent of this continuation

Application08/981,952Parent of this continuation

US 6,004,973 AParent of this continuation

US 6,599,535 B2This patent

From the US filing history. Foreign family members aren’t listed.

Pharmaceutical compositions

Life of this patent

Abstract

Claims8

Pharmaceutical compositions

Life of this patent

Abstract

Claims8